Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients
Tóm tắt
Different studies have reported various values for the percentage of patients with IL36RN mutations, and it has also been reported that the sites of these mutations differ among different ethnicities. The current study was a cross-sectional study conducted to investigate the risk factors predicting IL36RN mutation in Chinese patients with different clinical features of pustular psoriasis. 57 Han Chinese patients, including 32 with generalized pustular psoriasis, 14 with palmoplantar pustulosis, 9 with plaque-type psoriasis with pustules, and 2 with erythrodermic psoriasis, were enrolled between March 2013 and July 2014. Blood samples were collected, genomic DNA was extracted from leukocytes, and polymerase chain reaction (PCR)-based Sanger sequencing was used to analyze the coding exons and flanking introns of the IL36RN gene. The patients with generalized pustular psoriasis exhibited the highest IL36RN mutation rate (75 %) among the aforementioned patient types, with the subgroup consisting of those patients who had features of acrodermatitis continua of Hallopeau exhibiting the highest c.115+6T>C mutation rate (93.8 %). In addition, early onset, ever generalized pustular psoriasis (more than two attacks), ever acrodermatitis continua of Hallopeau, inverse psoriasis, and a family history of pustular psoriasis were associated with IL36RN mutation. The c.115+6T>C mutation was the most common and the most important variant in all subtypes of pustular psoriasis with IL36RN mutations among our sample of Chinese patients.
Tài liệu tham khảo
Capon F (2013) IL36RN mutations in generalized pustular psoriasis: just the tip of the iceberg? J Invest Dermatol 133:2503–2504
Chiu HY, Huang PY, Jee SH, Hu CY, Chou CT, Chang YT et al (2012) HLA polymorphism among Chinese patients with chronic plaque psoriasis: subgroup analysis. Br J Dermatol 166:288–297
Farley E, Masrour S, McKey J, Menter A (2009) Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool. J Am Acad Dermatol 60:1024–1031
Farooq M, Nakai H, Fujimoto A, Fujikawa H, Matsuyama A, Kariya N et al (2013) Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis. Hum Mutat 34:176–183
Gokdemir G, Kutlu S, Köşlü A (2009) Acrodermatitis continua resistant to etanercept: therapeutic challenge and unfortunate outcome. J Eur Acad Dermatol Venereol 23:345–347
Hussain S, Berki DM, Choon SE, Burden AD, Allen MH, Arostegui JI et al (2015) IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis. J Allergy Clin Immunol 135(1067–70):e9
Iizuka H, Takahashi H, Ishida-Yamamoto A (2003) Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res 295(Suppl 1):S55–S59
Körber A, Mössner R, Renner R, Sticht H, Wilsmann-Theis D, Schulz P et al (2013) Mutations in IL36RN in patients with generalized pustular psoriasis. J Invest Dermatol 133:2634–2637
Kanazawa N, Nakamura T, Mikita N, Furukawa F (2013) Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis. J Dermatol 40:749–751
Li M, Lu Z, Cheng R, Li H, Guo Y, Yao Z (2013) IL36RN gene mutations are not associated with sporadic generalized pustular psoriasis in Chinese patients. Br J Dermatol 168:452–455
Li M, Han J, Lu Z, Li H, Zhu K, Cheng R et al (2013) Prevalent and rare mutations in IL-36RN gene in Chinese patients with generalized pustular psoriasis and psoriasis vulgaris. J Invest Dermatol 133:2637–2639
Li X, Chen M, Fu X, Zhang Q, Wang Z, Yu G et al (2014) Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with/without psoriasis vulgaris. J Dermatol Sci 76:132–138
Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S et al (2011) Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 365:620–628
Mulero JJ, Pace AM, Nelken ST, Loeb DB, Correa TR, Drmanac R et al (1999) IL1HY1: a novel interleukin-1 receptor antagonist gene. Biochem Biophys Res Commun 263:702–706
Navarini AA, Valeyrie-Allanore L, Setta-Kaffetzi N, Barker JN, Capon F, Creamer D et al (2013) Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis. J Invest Dermatol 133:1904–1907
Onoufriadis A, Simpson MA, Pink AE, Di Meglio P, Smith CH, Pullabhatla V et al (2011) Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet 89:432–437
Setta-Kaffetzi N, Navarini AA, Patel VM, Pullabhatla V, Pink AE, Choon SE et al (2013) Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. J Invest Dermatol 133:1366–1369
Sugiura K, Oiso N, Iinuma S, Matsuda H, Minami-Hori M, Ishida-Yamamoto A et al (2014) IL36RN mutations underlie impetigo herpetiformis. J Invest Dermatol 134:2472–2474
Sugiura K, Takemoto A, Yamaguchi M, Takahashi H, Shoda Y, Mitsuma T et al (2013) The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Invest Dermato 133:2514–2521
Sims JE, Smith DE (2010) The IL-1 family: regulators of immunity. Nat Rev Immunol 10:89–102
Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC (2001) Acute generalized exanthematous pustulosis (AGEP)–a clinical reaction pattern. J Cutan Pathol 28:113–119
Towne JE, Garka KE, Renshaw BR, Renshaw BR, Virca GD, Sims JE (2004) Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem 279:13677–13688
Tsai TF, Hu CY, Tsai WL, Chu CY, Lin SJ, Liaw SH et al (2002) HLA-Cw6 specificity and polymorphic residues are associated with susceptibility among Chinese psoriatics in Taiwan. Arch Dermatol Res 294:214–220